BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15459215)

  • 1. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia.
    Relling MV; Yang W; Das S; Cook EH; Rosner GL; Neel M; Howard S; Ribeiro R; Sandlund JT; Pui CH; Kaste SC
    J Clin Oncol; 2004 Oct; 22(19):3930-6. PubMed ID: 15459215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the Relationship Between
    Erdem M; Tüfekçi Ö; Kızıldağ S; Yılmaz Ş; Kızmazoğlu D; Eroğlu Filibeli B; Ören H
    Turk J Haematol; 2019 Feb; 36(1):12-18. PubMed ID: 30251958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphism of vitamin D receptors and plasminogen activator inhibitor-1 and osteonecrosis risk in childhood acute lymphoblastic leukemia.
    Sherief LM; Beshir M; Raafat N; Abdelkhalek ER; Mokhtar WA; Elgerby KM; Soliman BK; Salah HE; Mokhtar GA; Kamal NM; ELsayed H; Zakaria M
    Mol Genet Genomic Med; 2021 Jul; 9(7):e1700. PubMed ID: 34042331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.
    Kawedia JD; Kaste SC; Pei D; Panetta JC; Cai X; Cheng C; Neale G; Howard SC; Evans WE; Pui CH; Relling MV
    Blood; 2011 Feb; 117(8):2340-7; quiz 2556. PubMed ID: 21148812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A thymidylate synthase polymorphism is associated with increased risk for bone toxicity among children treated for acute lymphoblastic leukemia.
    Finkelstein Y; Blonquist TM; Vijayanathan V; Stevenson KE; Neuberg DS; Silverman LB; Vrooman LM; Sallan SE; Cole PD
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27957785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A
    Zgheib NK; El-Khoury H; Maamari D; Basbous M; Saab R; Muwakkit SA
    Per Med; 2021 Sep; 18(5):431-439. PubMed ID: 34406079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia.
    Karol SE; Yang W; Van Driest SL; Chang TY; Kaste S; Bowton E; Basford M; Bastarache L; Roden DM; Denny JC; Larsen E; Winick N; Carroll WL; Cheng C; Pei D; Fernandez CA; Liu C; Smith C; Loh ML; Raetz EA; Hunger SP; Scheet P; Jeha S; Pui CH; Evans WE; Devidas M; Mattano LA; Relling MV
    Blood; 2015 Oct; 126(15):1770-6. PubMed ID: 26265699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    French D; Hamilton LH; Mattano LA; Sather HN; Devidas M; Nachman JB; Relling MV;
    Blood; 2008 May; 111(9):4496-9. PubMed ID: 18285546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic predictors of glucocorticoid-induced hypertension in children with acute lymphoblastic leukemia.
    Kamdem LK; Hamilton L; Cheng C; Liu W; Yang W; Johnson JA; Pui CH; Relling MV
    Pharmacogenet Genomics; 2008 Jun; 18(6):507-14. PubMed ID: 18496130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Biomarkers to Identify the Risk of Osteonecrosis in Children with Acute Lymphoblastic Leukemia.
    den Hoed MA; Pluijm SM; Uitterlinden AG; Pieters R; van den Heuvel-Eibrink MM
    Mol Diagn Ther; 2016 Dec; 20(6):519-522. PubMed ID: 27365083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids.
    Kaste SC; Pei D; Cheng C; Neel MD; Bowman WP; Ribeiro RC; Metzger ML; Bhojwani D; Inaba H; Campbell P; Rubnitz JE; Jeha S; Sandlund JT; Downing JR; Relling MV; Pui CH; Howard SC
    J Clin Oncol; 2015 Feb; 33(6):610-5. PubMed ID: 25605853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Osteonecroses of the bilateral tali during maintenance therapy in a child with acute lymphoblastic leukemia].
    Nozaki H; Matsubara K; Mori S
    Rinsho Ketsueki; 2006 Feb; 47(2):106-10. PubMed ID: 16529012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia.
    te Winkel ML; Pieters R; Hop WC; de Groot-Kruseman HA; Lequin MH; van der Sluis IM; Bökkerink JP; Leeuw JA; Bruin MC; Egeler RM; Veerman AJ; van den Heuvel-Eibrink MM
    J Clin Oncol; 2011 Nov; 29(31):4143-50. PubMed ID: 21947829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteonecrosis of the Shoulders in Pediatric Patients Treated for Leukemia or Lymphoma: Single-Institutional Experience.
    Kaste SC; DeFeo BM; Neel MD; Weiss KS; Fernandez-Pineda I; Ness KK
    J Pediatr Orthop; 2019 Feb; 39(2):104-110. PubMed ID: 28452860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacogenetic analysis of risk polymorphisms in Caucasian and Vietnamese children with acute lymphoblastic leukemia: prediction of therapeutic outcome?
    Hoang PT; Ambroise J; Dekairelle AF; Durant JF; Butoescu V; Chi VL; Huynh N; Nguyen TB; Robert A; Vermylen C; Gala JL
    Br J Clin Pharmacol; 2015 Mar; 79(3):429-40. PubMed ID: 25099492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteonecrosis is unrelated to hip anatomy in children with acute lymphoblastic leukemia.
    Portera MV; Karol SE; Smith C; Yang W; Cheng C; Neel MD; Pui CH; Relling MV; Kaste SC
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28035753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteonecrosis in children with acute lymphoblastic leukemia.
    Kunstreich M; Kummer S; Laws HJ; Borkhardt A; Kuhlen M
    Haematologica; 2016 Nov; 101(11):1295-1305. PubMed ID: 27742768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships among severity of osteonecrosis, pain, range of motion, and functional mobility in children, adolescents, and young adults with acute lymphoblastic leukemia.
    Marchese VG; Connolly BH; Able C; Booten AR; Bowen P; Porter BM; Rai SN; Hancock ML; Pui CH; Howard S; Neel MD; Kaste SC
    Phys Ther; 2008 Mar; 88(3):341-50. PubMed ID: 18202079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia.
    Karol SE; Mattano LA; Yang W; Maloney KW; Smith C; Liu C; Ramsey LB; Fernandez CA; Chang TY; Neale G; Cheng C; Mardis E; Fulton R; Scheet P; San Lucas FA; Larsen EC; Loh ML; Raetz EA; Hunger SP; Devidas M; Relling MV
    Blood; 2016 Feb; 127(5):558-64. PubMed ID: 26590194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of osteonecrosis in pediatric acute lymphoblastic leukemia and general populations.
    Yang W; Devidas M; Liu Y; Smith C; Dai Y; Winick N; Hunger SP; Loh ML; Raetz EA; Larsen EC; Carroll WL; Winter SS; Dunsmore KP; Mattano LA; Relling MV; Karol SE
    Blood; 2021 Mar; 137(11):1550-1552. PubMed ID: 33106839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.